Caplin Point Laboratories Ltd. (CAPLIPOINT): Caplin Point Laboratories Share Price rises 2.29% today

Published: 22 September 2026 at 10:18:44 AM IST

Caplin Point Laboratories Share Price was Rs 2,820 on 22 September 2026 at 10:18:44 AM IST, up 2.29% from the previous close of Rs 2,756.90. The stock added Rs 63.10 during the session and the company’s market capitalisation stood at Rs 20,886.87 crore. The day’s range stretched from Rs 2,710 to Rs 2,838.90, while turnover was Rs 1.43 crore. This Caplin Point Laboratories Share Price move confirms a same-day price rise, but the supplied data does not establish a company-specific catalyst. For readers tracking Caplin Point Laboratories Share Price Today, the main takeaway is the verified price action and the valuation backdrop in healthcare. Univest is following the move as part of the latest Caplin Point Laboratories Stock News and broader Caplin Point Laboratories Stock Analysis.

In Caplin Point Laboratories Share Price Today terms, the stock opened at Rs 2,743.70 and traded above the previous close through the session to the current level. The move makes Caplin Point Laboratories Share News relevant for investors who monitor daily price action alongside fundamentals, sector comparison and market capitalisation. Univest’s coverage focuses on what the numbers show today, not on an unverified reason. That keeps the analysis factual and useful for readers looking for Caplin Point Laboratories Latest News, Caplin Point Laboratories Share Price Update and Caplin Point Laboratories Stock Performance.

The intraday path also matters because the stock was able to hold well above the opening level and finish near the session high. That pattern supports the view that the Caplin Point Laboratories Share Price strength was broad enough to stay intact throughout the session, even though no additional corporate trigger is available in the supplied data. The range between the low of Rs 2,710 and the high of Rs 2,838.90 shows active movement, while the turnover figure of Rs 1.43 crore gives a useful scale for the day without changing the fact that the day’s core story is the percentage rise.

Caplin Point Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,820
Previous Close	Rs 2,756.9
Today's Move	Rs 63.1 (+2.29%)
Open	Rs 2,743.7
High	Rs 2,838.9
Low	Rs 2,710
Turnover	Rs 1.43 crore
Market Capitalisation	Rs 20,886.87 crore
Market Cap Category	Large Cap

Caplin Point Laboratories Ltd. (CAPLIPOINT) rose to Rs 2,820 from the previous close of Rs 2,756.9, a move of Rs 63.1 or 2.29%. The stock opened at Rs 2,743.7, reached a high of Rs 2,838.9, recorded a low of Rs 2,710.

Caplin Point Laboratories Share Price Today rose Rs 63.10, or 2.29%, to Rs 2,820. The stock moved between Rs 2,710 and Rs 2,838.90, with the current quote sitting close to the session high and above the opening level of Rs 2,743.70. Compared with the previous close of Rs 2,756.90, the day shows a clear upward move in Caplin Point Laboratories Stock News terms. The verified figures explain what happened today; they do not establish why the move occurred. For market watchers scanning Stocks in News or Top Gainers Today, this is a straightforward price rise backed by exact session data and turnover of Rs 1.43 crore.

The price action also shows that the session began only modestly below the day’s peak and then expanded higher as trading progressed. That matters for Caplin Point Laboratories Share Price readers because it indicates the stock did not merely gap up and fade; it remained firm enough to keep most of the gains into the latest quote. In a daily update, that kind of behaviour is more informative than a raw closing number alone, especially when the article is limited to verified data and cannot attribute the rise to any specific catalyst.

Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 20,886.87 crore
P/E Ratio	31.5x
P/B Ratio	5.71x
ROE	20.79%
ROCE	24.97%
EPS	Rs 87.53
Book Value Per Share	Rs 483.17
Dividend Yield	0.29%

Caplin Point Laboratories Ltd. (CAPLIPOINT) fundamental metrics show P/E 31.5x, P/B 5.71x, ROE 20.79%, ROCE 24.97%. These figures provide context only and are not a buy or sell signal.

Caplin Point Laboratories Ltd. has a market capitalisation of Rs 20886.87 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.5x, P/B at 5.71x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.79% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 87.53, book value per share of Rs 483.17, dividend yield of 0.29%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.62x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	31.5x
Benchmark Median P/E	32.62x
Benchmark Average P/E	49.51x
Benchmark P/E Range	3.37x to 747.32x
Company P/B Ratio	5.71x
Benchmark Median P/B	3x
Company ROE	20.79%
Benchmark Median ROE	11.74%
Company ROCE	24.97%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 20,886.87 crore
Benchmark Median Market Cap	Rs 746.45 crore

Caplin Point Laboratories Ltd. (CAPLIPOINT) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.5x, which is below the benchmark median of 32.62x, a difference of -3.43%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROE of 20.79%, which is above the benchmark median of 11.74%, a difference of +77.09%. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROCE of 24.97%, which is above the benchmark median of 13.63%, a difference of +83.2%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,40,397.93	37.05	5.18	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,48,664.42	85.6	14.18	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,82,738.23	86.64	21.05	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,012.19	25.67	4.3	19.69	21.39
Cipla Ltd.	CIPLA	1,10,793.75	33.19	3.18	11.83	16

Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.5x compared with the displayed peer median of 37.05x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.79% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 20,886.87 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Caplin Point Laboratories

• Caplin Point Laboratories Share Price rose 2.29% today to Rs 2,820.
• The stock moved Rs 63.10 above the previous close of Rs 2,756.90.
• Turnover stood at Rs 1.43 crore during the session.
• Market capitalisation was Rs 20,886.87 crore.
• P/E of 31.5, ROE of 20.79% and ROCE of 24.97% frame the valuation discussion.

About Caplin Point Laboratories

Caplin Point Laboratories Ltd. is part of the Pharmaceuticals & Drugs industry within Healthcare. The company’s share price movement today places Caplin Point Laboratories Share Price in the centre of stock market discussion, but the business context remains the more durable reference point. For investors reviewing Caplin Point Laboratories Stock News or Caplin Point Laboratories Company News, the key focus is how the company’s listed metrics and healthcare positioning fit into the broader sector. The company operates as a pharmaceutical business, and its reported valuation ratios, earnings and return measures are the main public data points available in this update. In that sense, Caplin Point Laboratories Share Price Today is best understood alongside company fundamentals, sector comparison and market capitalisation rather than in isolation. Univest presents the Caplin Point Laboratories Share Price story as part of a wider financial analysis view.

For a stock like Caplin Point Laboratories, the daily move is only one part of the picture. The current update combines the session range, turnover, market capitalisation and peer metrics so readers can place the rise in a structured framework. That approach is especially useful when no separate corporate event has been supplied, because it keeps the article tied to verified market data.

Track Caplin Point Laboratories Share Price on Univest

Use Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Frequently Asked Questions

Why did Caplin Point Laboratories Share Price rise today?

Ans. Caplin Point Laboratories Share Price rose 2.29% to Rs 2,820 today. The supplied data confirms the price move, but it does not establish a company-specific catalyst for the session. The previous close was Rs 2,756.9.

What is Caplin Point Laboratories Share Price today?

Ans. Caplin Point Laboratories Share Price today is Rs 2,820. It was up Rs 63.10 from the previous close of Rs 2,756.90, showing a verified same-day share price rise. The previous close was Rs 2,756.9.

What is the market capitalisation of Caplin Point Laboratories?

Ans. Caplin Point Laboratories has a market capitalisation of Rs 20,886.87 crore. That places Caplin Point Laboratories Share Price within a sizeable listed healthcare company context. The company operates in the Healthcare sector.

What do Caplin Point Laboratories valuation ratios show?

Ans. Caplin Point Laboratories trades at a P/E of 31.5 and a P/B of 5.71. Those figures sit within the healthcare peer range and help frame Caplin Point Laboratories Share Price.

How strong are Caplin Point Laboratories profitability ratios?

Ans. Caplin Point Laboratories reports ROE of 20.79% and ROCE of 24.97%. Those return ratios are above the same-industry median and average, adding context to Caplin Point Laboratories Share Price. ROE stands at 20.79%.